Soligenix (SNGX) Intangibles (2010 - 2020)
Soligenix's (SNGX) quarterly Intangibles came in at $2.4 million in Q4 2020, up 11857.05% YoY from N/an in Q1 2020, and little changed on a QoQ basis from $2.4 million in Q3 2020.
Soligenix (SNGX) Intangibles (2010 - 2020) Analysis & Trends
Soligenix (SNGX) has 11 years of Intangibles data on file, last reported at $2.4 million in Q4 2020.
- Quarterly Intangibles rose 11857.05% year-over-year to $2.4 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $2.4 million (up 11857.05% YoY) and the FY2020 annual result came in at $2.4 million, up 11857.05% from the prior year.
- Intangibles held at $2.4 million in Q4 2020, from $2.4 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $2.4 million in Q3 2020 to a low of $6117.0 in Q2 2020.
- A 5-year average of $301979.4 and a median of $70594.0 in 2017 frame the typical range for Intangibles.
- The widest YoY moves for Intangibles: up 11857.05% in 2020, down 81.62% in 2020.
- Tracing SNGX's Intangibles over 5 years: stood at $126628.0 in 2016, then sank by 41.6% to $73952.0 in 2017, then sank by 36.63% to $46863.0 in 2018, then plunged by 57.96% to $19699.0 in 2019, then surged by 11857.05% to $2.4 million in 2020.
- The last three Intangibles figures came in at $2.4 million (Q4 2020), $2.4 million (Q3 2020), and $6117.0 (Q2 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Soligenix | 6.45 Mn | 6.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 2.36 Mn |
| Sep 30, 2020 | 2.36 Mn |
| Jun 30, 2020 | 6,117.00 |
| Mar 31, 2020 | 12,908.00 |
| Dec 31, 2019 | 19,699.00 |
| Sep 30, 2019 | 26,490.00 |
| Jun 30, 2019 | 33,281.00 |
| Mar 31, 2019 | 40,072.00 |
| Dec 31, 2018 | 46,863.00 |
| Sep 30, 2018 | 53,653.00 |
| Jun 30, 2018 | 60,445.00 |
| Mar 31, 2018 | 67,236.00 |
| Dec 31, 2017 | 73,952.00 |
| Sep 30, 2017 | 80,818.00 |
| Jun 30, 2017 | 95,781.00 |
| Mar 31, 2017 | 111,290.00 |
| Dec 31, 2016 | 126,628.00 |
| Sep 30, 2016 | 142,308.00 |
| Jun 30, 2016 | 157,896.00 |
| Mar 31, 2016 | 173,314.00 |